ANR 5.88% 4.8¢ anatara lifesciences ltd

Investor presentation page 17: "Zoetis will work to develop...

  1. 144 Posts.
    lightbulb Created with Sketch. 3
    Investor presentation page 17: "Zoetis will work to develop Detach® for use in a range of livestock species and horses. This is a significant development effort which would have been outside of Anatara’s capacity as a small company."

    Investor presentation page 19: "What’s next? • Anatara team to now focus on development of human pipeline "

    I would have though the human pipeline would have been a much more costly channel to develop.
 
watchlist Created with Sketch. Add ANR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.